Carestream’s New Native Lesion Management Module for Vue PACS Receives FDA Clearance

Lesion Management Tools Designed to Enable Semi-Automatic Comparisons on Company’s Vue PACS Workstation

ROCHESTER, N.Y--(BUSINESS WIRE)--Carestream received U.S. Food and Drug Administration (FDA) clearance for its new lesion management module, which is a native oncology follow-up application that can be added for its Vue PACS. Carestream will demonstrate its lesion management tools on a Vue PACS workstation at the upcoming Radiological Society of North America (RSNA) tradeshow. The lesion management module is now available for order.

“The comparison results are displayed with each exam and can be embedded into the final diagnostic report for other clinicians for review.”

Carestream’s new lesion management tools (see video demo) are designed to enhance assessment of oncology patients by providing semi-automatic tracking and segmentation of lesions from modalities and other vendors’ PACS systems. Each measurement generates an anatomical bookmark within the exam, which radiologists can easily navigate and diagnose.

“The proven volumetric registration combined with the new lesion management feature in our Vue PACS synchronizes views from current and prior exams, which makes it much faster and easier for radiologists to measure and compare lesions, as well as tumors, nodules and other anatomical structures,” said Cristine Kao, Carestream’s Global Marketing Manager for Healthcare Information Solutions. “The comparison results are displayed with each exam and can be embedded into the final diagnostic report for other clinicians for review.”

Carestream’s new lesion management capabilities are designed to help enhance both diagnostic confidence and radiologist productivity. Making these tools available as an optional native PACS module helps eliminate the cost of dedicated workstations.

Carestream’s lesion management application also can equip radiologists with the ability to generate comprehensive oncology imaging reports in accordance with industry standards such as Response Evaluation Criteria in Solid Tumors (RECIST). Consistent, standardized oncology image reporting allows for clearer and more meaningful communication and collaboration between radiologists, oncologists and referring physicians.

For more information on Carestream’s medical imaging and healthcare IT solutions please visit www.carestream.com.

About Carestream Health

Carestream Health is a worldwide provider of dental and medical imaging systems and healthcare IT solutions; X-ray film and digital X-ray systems for non-destructive testing; and advanced materials for the precision films and electronics markets.

For more information about the company’s broad portfolio of products, solutions and services, please contact your Carestream Health representative or visit www.carestream.com.

CARESTREAM is a trademark of Carestream Health.

Follow Carestream Health online:

http://www.twitter.com/carestream
http://www.youtube.com/carestream
http://blog.carestreamhealth.com/
http://www.facebook.com/carestream

2012